Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.431 USD | +7.75% | +1.17% | +42.36% |
15/05 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.36% | 4.02Cr | |
+60.72% | 6.26TCr | |
-2.98% | 4.12TCr | |
+44.47% | 4.03TCr | |
-8.29% | 2.79TCr | |
+12.77% | 2.62TCr | |
-21.74% | 1.91TCr | |
+5.86% | 1.31TCr | |
+24.15% | 1.23TCr | |
+26.96% | 1.21TCr |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc. Presents at H.C. Wainwright BioConnect 2021 Conference, Jan-11-2021 06